Pacira BioSciences has patented a method for treating hip pain by administering a pharmaceutical composition containing bupivacaine phosphate encapsulated in multivesicular liposomes. The method aims to reduce the need for non-opioid analgesics post hip treatment, administered through needle injection in a specific anatomical location. GlobalData’s report on Pacira BioSciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to GlobalData’s company profile on Pacira BioSciences, Cancer treatment biomarkers was a key innovation area identified from patents. Pacira BioSciences's grant share as of February 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Method of reducing non-opioid analgesic post hip treatment
A recently granted patent (Publication Number: US11918688B2) discloses a method for reducing the amount of non-opioid analgesics administered to a subject following hip treatment. The method involves administering a pharmaceutical composition containing multivesicular liposomes encapsulating bupivacaine phosphate. The composition is administered via needle injection in a specific manner, with the needle tip positioned between the anterior inferior iliac spine and psoas tendon, away from the musculofascial plane. The pharmaceutical composition aims to provide effective pain relief while minimizing the need for opioid analgesics post-treatment.
The patent further details the components of the pharmaceutical composition, including amphipathic lipids, neutral lipids, bupivacaine or its salt, and a process for preparing multivesicular liposomes. The method focuses on precise administration techniques to reduce hip pain in subjects, with specific guidelines on needle length, diameter, and insertion mode relative to an imaging transducer. By utilizing this innovative approach, the method aims to achieve optimal pain management outcomes while minimizing the use of opioids following hip treatment, showcasing a potential advancement in post-operative care strategies for hip procedures.
To know more about GlobalData’s detailed insights on Pacira BioSciences, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
